Penbex 200IU/ml+250mg/ml+0,5mg/ml+8mg/ml+15mg/ml suspension for injection

Country: Հայաստան

language: անգլերեն

source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

active_ingredient:

penicillin G procaine, dihydrostreptomycin sulfate, betamethasone, chlorphenamine maleate, procaine hydrochloride

MAH:

Invesa Industrial Veterinaria

ATC_code:

QJ01RA01

INN:

penicillin G procaine, dihydrostreptomycin sulfate, betamethasone, chlorphenamine maleate, procaine hydrochloride

dosage:

200IU/ml+250mg/ml+0,5mg/ml+8mg/ml+15mg/ml

pharmaceutical_form:

suspension for injection

units_in_package:

glass vial 10ml, glass vial 50ml, glass vial 100ml

prescription_type:

Prescription

authorization_status:

Registered

authorization_date:

2015-02-26

SPC

SUMMARY OF CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE VETERINARY MEDICINAL PRODUCT
PENBEX
Suspension for injection
Intramuscular route
For veterinary use
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
Active substances:
Penicillin G procaine...............................................
200,000 IU
Dihydrostreptomycin sulfate ..................................... 250
mg
Betamethasone sodium phosphate ........................... 0.5 mg
Chlorphenamine maleate ............................................. 8
mg
Procaine hydrochloride ...............................................
15 mg
Excipients:
For a full list of excipients, see section 6.1
3. PHARMACEUTICAL FORM
Suspension for injection
4. CLINICAL PARTICULARS
4.1. TARGET SPECIES
Cattle, Swine, Horses, Sheep, Goats, Dogs and Cats.
4.2. INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of bacterial infections caused by germs sensitive to the
association penicillin-
dihydrostreptomycin sulfate.
4.3. CONTRAINDICATIONS
Do not use in case of hypersensitive animals to any component of the
veterinary medicine.
4.4. SPECIAL WARNINGS
None
4.5. SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Suspension may be used as many times as necessary, when aseptic
precautions are carried
out on taking the necessary doses. Length of treatment will be
determined by the veterinary
depending on the severity of the disease. The average length is three
days.
Do not administer in horses producing meat for human consumption.
Special precautions to be taken by the person administering the
veterinary medicinal product
to animals
Not applicable
4.6. ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Allergic
reactions
may
appear
in
sensitized
animals,
and
they
will
be
treated
with
antihistaminics and/or corticosteroids.
4.7. USE DURING PREGNANCY, LACTATION OR LAY
The use is not recommended at the end of gestation (last third) it can
advance parturition in
cattle.
4.8. INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
IN